N Giladi1, E Melamed. Show Affiliations » 1. Department of Neurology, Tel Aviv Medical Center, Israel.
Abstract
Entities: Chemical Disease
Mesh： See more » AgedAntiparkinson Agents/therapeutic useBlepharospasm/drug therapyDyskinesia, Drug-Induced/diagnosisDyskinesia, Drug-Induced/drug therapyFemaleHumansLevodopa/therapeutic useMiddle AgedNeurologic Examination/drug effectsParkinson Disease, Secondary/chemically inducedParkinson Disease, Secondary/drug therapyRecurrenceSulpiride/administration & dosageSulpiride/adverse effectsTetrabenazine/administration & dosageTetrabenazine/adverse effects
Substances： See more » Antiparkinson AgentsLevodopaSulpirideTetrabenazine
Year: 1999 PMID： 9918362 DOI： 10.1002/1531-8257(199901)14:1<158::aid-mds1028>3.0.co;2-q
Source DB: PubMed Journal: Mov Disord ISSN： 0885-3185 Impact factor: 10.338